Ease of use of two autoinjectors in patients with multiple sclerosis treated with interferon beta-1a subcutaneously three times weekly: results of the randomized, crossover REDEFINE study.
Expert Opin Drug Deliv
; 15(2): 127-135, 2018 02.
Article
in En
| MEDLINE
| ID: mdl-29206056
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Adjuvants, Immunologic
/
Patient Satisfaction
/
Multiple Sclerosis, Relapsing-Remitting
/
Patient Preference
/
Interferon beta-1a
/
Injections, Subcutaneous
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
Limits:
Adolescent
/
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Expert Opin Drug Deliv
Journal subject:
FARMACOLOGIA
/
TERAPIA POR MEDICAMENTOS
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom